Peizeng Yang Selected Research

HLA-DR53

5/2009	Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.
1/2008	Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peizeng Yang Research Topics

Disease

75	Uveitis 05/2024 - 03/2002
51	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 11/2023 - 04/2002
43	Behcet Syndrome (Behcet's Syndrome) 10/2023 - 04/2002
27	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 05/2007
22	Inflammation (Inflammations) 01/2023 - 04/2002
15	Anterior Uveitis 02/2024 - 01/2013
11	Ankylosing Spondylitis 02/2024 - 01/2013
7	Hypersensitivity (Allergy) 01/2012 - 06/2006
6	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 01/2013
6	Cataract (Cataracts) 06/2020 - 01/2011
5	Necrosis 01/2023 - 05/2003
4	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 03/2002
3	Neoplasms (Cancer) 01/2023 - 08/2017
3	Glaucoma 01/2022 - 03/2002
3	Retinal Vasculitis 03/2021 - 01/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2023 - 01/2020
2	COVID-19 01/2023 - 12/2022
2	Infections 01/2022 - 01/2020
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2020 - 01/2013
1	Rheumatoid Arthritis 02/2023

Drug/Important Bio-Agent (IBA)

17	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2007
12	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 04/2002
11	CytokinesIBA 03/2024 - 05/2010
11	Retinaldehyde (Retinal)IBA 03/2024 - 03/2002
11	Messenger RNA (mRNA)IBA 01/2023 - 03/2007
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2007
8	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2023 - 05/2009
7	AntigensIBA 01/2018 - 03/2002
6	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2012
5	Interleukin-10 (Interleukin 10)IBA 02/2024 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
5	Fluorescein (Funduscein)FDA LinkGeneric 01/2023 - 04/2002
5	LigandsIBA 01/2020 - 01/2011
5	InterleukinsIBA 01/2015 - 10/2010
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2023 - 01/2008
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2016
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 07/2008
4	Prednisone (Sone)FDA LinkGeneric 09/2022 - 04/2002
4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 05/2007
4	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015 - 07/2009
3	InterferonsIBA 05/2024 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 07/2009
3	Long Noncoding RNAIBA 02/2023 - 11/2019
3	Peptides (Polypeptides)IBA 01/2023 - 07/2009
3	Fc Receptors (Fc Receptor)IBA 01/2023 - 01/2008
3	EndotoxinsIBA 01/2022 - 05/2003
3	Monocyte Chemoattractant ProteinsIBA 01/2020 - 08/2009
3	OvalbuminIBA 07/2008 - 06/2006
2	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2022
2	HLA-B51 AntigenIBA 11/2023 - 09/2013
2	HLA-A*26 antigenIBA 11/2023 - 01/2022
2	Oxidoreductases (Dehydrogenase)IBA 10/2023 - 01/2021
2	ImmunosorbentsIBA 01/2023 - 10/2008
2	EnzymesIBA 01/2023 - 10/2008
2	SaltsIBA 01/2023 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2018
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 04/2002
2	NucleotidesIBA 01/2022 - 12/2013
2	IGF-I-IGFBP-3 complex FDA Link 01/2021 - 01/2020
2	Vitamin D FDA LinkGeneric 01/2021 - 02/2014
2	BerberineIBA 04/2020 - 04/2013
2	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2020 - 09/2014
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018 - 01/2014
2	Carrier Proteins (Binding Protein)IBA 09/2017 - 04/2016
2	Interleukin-4 (Interleukin 4)IBA 09/2017 - 01/2017
2	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 08/2017 - 01/2017
2	ChemokinesIBA 01/2017 - 07/2009
2	C-Type Lectins (C-Type Lectin)IBA 01/2017 - 03/2015
2	Interleukin-1 (Interleukin 1)IBA 10/2016 - 07/2009
2	Complement System Proteins (Complement)IBA 08/2015 - 01/2015
2	P-2 (P 2)IBA 03/2015 - 02/2014
2	Complement C4 (Complement Component 4)IBA 01/2015 - 11/2013
2	Interleukin-27 (Interleukin 27)IBA 05/2014 - 07/2012
2	TNF Receptor-Associated Factor 5IBA 01/2014 - 01/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2013 - 01/2012
2	HLA-DR53IBA 05/2009 - 01/2008
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2009 - 01/2008
2	Interleukin-23 Subunit p19IBA 07/2008 - 05/2007
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 02/2024
1	4-octyl itaconateIBA 01/2024
1	Antirheumatic Agents (DMARD)IBA 11/2023
1	Succinic Acid (Succinate)IBA 11/2023
1	HLA-B15 AntigenIBA 11/2023
1	NADP (NADPH)IBA 10/2023
1	Mitogen-Activated Protein KinasesIBA 10/2023
1	Interleukin-8 (Interleukin 8)IBA 10/2023
1	Protein Tyrosine PhosphatasesIBA 02/2023
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 02/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2023
1	moesinIBA 01/2023
1	Adalimumab (Humira)FDA Link 01/2023
1	Guanosine Diphosphate (GDP)IBA 01/2023
1	5-hydroxymethylcytosineIBA 01/2023
1	ezrinIBA 01/2023
1	SterolsIBA 01/2023

Therapy/Procedure

10	Therapeutics 01/2023 - 07/2008
3	Transplantation 01/2021 - 01/2018
3	Phacoemulsification 06/2020 - 08/2012
1	Biological Therapy 10/2023